Contract notice: Antineoplastic agents Tender in Poland - 17545882
Tender notice from Poland, published on 24 Oct 2017.
Executive Summary
The WOJSKOWY INSTYTUT MEDYCZNY has issued a Tender notice for the procurement of a Contract notice: Antineoplastic agents in the Poland. This Tender notice was published on 24 Oct 2017 and is scheduled to close on 28 Nov 2017, with an estimated Tender value of Refer Document.
Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 17545882, while the tender notice number is 415366-2017 and Register on the platform.
Object of the contract Antineoplastic agents Description: Contract notice: Antineoplastic agents Authority Type: Body governed by public law Contact Nature: Supplies Procedure: Open procedure Document: Contract notice Regulation: European Union, with participation by GPA countries Award criteria: Lowest price CPV code: 33652100, 33652100, 33652100, 33652300, 33661000, 33620000, 33612000, 33651400, 33652000, 33622200, 33621000, 33621300, 33651520, 33650000, 33642100, 33622000, 33651600, 33632200, 33631300, 33661100, 33141530, 33622400, 33661300, 33675000, 33651100, 33642000, 33651200, 33641000, 33696000, 33670000, 33692200, 33600000, 24322000, 33695000, 33141310, 33141320, 33141624, 33194120, 33631600 CPV Description: Antineoplastic agents. Immunosuppressive agents. Medicinal products for the nervous system. Medicinal products for the blood, blood-forming organs and the cardiovascular system. Medicinal products for functional gastrointestinal disorders. Antivirals for systemic use. Antineoplastic and immunomodulating agents. Antihypertensives. Medicinal products for the blood and blood-forming organs. Antianaemic preparations. Immunoglobulins. General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents. Pituitary, hypothalamic hormones and analogues. Medicinal products for the cardiovascular system. Vaccines. Muscle relaxants. Antipsoriatics. Anaesthetics. Blood coagulants. Vasoprotectives. Antiepileptics. Antihistamines for systemic use. Antibacterials for systemic use. Systemic hormonal preparations, excl. sex hormones. Antimycotics for systemic use. Medicinal products for the genitourinary system and sex hormones. Reagents and contrast media. Medicinal products for the respiratory system. Parenteral nutrition products. Pharmaceutical products. Alcohols, phenols, phenol-alcohols and their halogenated, sulphonated, nitrated or nitrosated derivatives; industrialfatty alcohols. All other non-therapeutic products. Syringes. Medical needles. Administration sets. Infusion supplies. Antiseptics and disinfectants. Dostawa produktow leczniczych. Reference Number : 103/ZP/17-18/Apteka/2017 Dostawa produktow leczniczych 127zadań, szczegołowy opis przedmiotu zamowienia zawiera Załącznik Nr 1 do SIWZ. Main Site : Miejsce realizacji dostaw siedziba zamawiającego-expos- of the Pharmacy Pharmacy. Acidum zolendronicum 1 assortment item. When placing an offer for medicinal products for the award of the contract may apply to the Contractor, who meet the conditions set out in art. 22 sec. 1b of the Act, concerning the competence or powers to conduct a specific occupational activity, as provided for by separate regulations. The performer will meet the warunek if he demonstrates that he has the power to trade in medicinal products in accordance with the Act of 6 September 2001r. Pharmaceutical law (Journal of Laws 2016, item 2142, as amended), that is, if it holds a permit or document confirming that the Contractor is entered in one of the professional or trade registers kept in a Member State of the European Union, homosexuality or place of residence; The terms and conditions of the exclusion and the list of declarations and documents confirming the fulfillment of the conditions of the proceedings and defining the absence of grounds for exclusion are included in the SIWZ in Chapters 5 and 6. 3. The offered goods should have the documents permitting to market and use in accordance with the requirements set out in: a) the Act of 6 September 2001r. The Pharmaceutical Law (Journal of Laws of 2016, item 2142, as amended) concerns medicinal products b) Act of 20 May 2010r. about medical devices (Journal of Laws of 2017, item 211, as amended) concerns medical devices 4. Medicinal products from tzMedication programs and chemotherapeutic drugs must be included in the current Health Minister's notice under Part B "Medication available under the Drug Program" and in Part C "Medication for chemotherapy in the whole range of indications and intentions and in indication of the condition Clinical ", unless in the description of the subject of the order in the Assortment Sheet cenumerated in Annex 1 to SIWZ, the specific scope of indications is listed. Only contractors who are not subject to exclusion from the procedure pursuant to Art. Article 24 1 of the Act of 29 January 2004 on the Law of Public Duties (Journal of Laws of 2017, item 1579, as amended). The ordering party will exclude from the procedure for awarding the contractor the Contractor on the basis of arVol. 5 of the Act of 29 January 2004 on Public Involvement (Journal of Laws of 2017, item 1579, as amended): a) in relation to which liquidation has been opened, in an approved court arrangement in the restructuring proceedings provided for the satisfaction of creditors by the liquidation of its assets or the court ordered the liquidation of its assets pursuant to art. 332 sec. 1 of the Act of 15 May 2015. Prestructuring agreement (Journal of Laws of 2015, item 978, 1259, 1513, 1830 and 1844, and 2016, item 615) or declared bankrupt, except for the Contractor, who, after bankruptcy, has entered into an agreement approved by a final court decision if the arrangement does not provide for the satisfaction of creditors by liquidating the assets of the bankrupt unless the court has ordered the liquidation of its assets pursuant to Art. 366 usArticle 1 of the Act of 28 February 2003 on Bankruptcy Law (Journal of Laws of 2015, item 233, 978, 1166, 1259 and 1844 and 2016, item 615); on his side, did not perform or unsuccessfully performed a prior agreement on a public order or concession contract concluded with the contracting authority referred to in art. 3 sec. 1 point 1 4 of the Act, which led dto terminate the contract or to award damages; c) who has violated obligations regarding the payment of taxes, charges or social security contributions, as the ordering party is able to demonstrate by means of appropriate evidence, except in the case referred to in art. Article 24 1 point 15 of the Act, unless the Contractor has paid taxes, fees or insurance contributionssocial or health insurance with interest or fines or have entered into a binding agreement on the repayment of those debts. Contractors jointly applying for a contract (consortium) conditions for participation in the proceedings may meet together. None of the Contractors acting jointly may be subject to exclusion pursuant to art. Article 24 1 and 2. 5 points 1, 4 and 8 of the Act of 29 sec2004 Public Procurement Law (Journal of Laws of 2017, item 1579, as amended). Internet address (URL): http://www.wim.mil.pl Directive: Classical Directive (2014/24/EU)
The bid deadline for Contract notice: Antineoplastic agents was 28 Nov 2017. Bidding is closed.
This tender has been issued by WOJSKOWY INSTYTUT MEDYCZNY in Poland.
The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.
This tender is Self Financed
The tender is classified under the following CPV code(s): 33652100 - Antineoplastic agents, 33652300 - Immunosuppressive agents, 33661000 - Medicinal products for the nervous system, 33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system, 33612000 - Medicinal products for functional gastrointestinal disorders, 33651400 - Antivirals for systemic use, 33652000 - Antineoplastic and immunomodulating agents, 33622200 - Antihypertensives, 33621000 - Medicinal products for the blood and blood-forming organs, 33621300 - Antianaemic preparations, 33651520 - Immunoglobulins, 33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, 33642100 - Pituitary, hypothalamic hormones and analogues, 33622000 - Medicinal products for the cardiovascular system, 33651600 - Vaccines, 33632200 - Muscle relaxants, 33631300 - Antipsoriatics, 33661100 - Anaesthetics, 33141530 - Blood coagulants, 33622400 - Vasoprotectives, 33661300 - Antiepileptics, 33675000 - Antihistamines for systemic use, 33651100 - Antibacterials for systemic use, 33642000 - Systemic hormonal preparations, excl. sex hormones, 33651200 - Antimycotics for systemic use, 33641000 - Medicinal products for the genitourinary system and sex hormones, 33696000 - Reagents and contrast media, 33670000 - Medicinal products for the respiratory system, 33692200 - Parenteral nutrition products, 33600000 - Pharmaceutical products, 24322000 - Alcohols, phenols, phenol-alcohols and their halogenated, sulphonated, nitrated or nitrosated derivatives; industrial fatty alcohols, 33695000 - All other non-therapeutic products, 33141310 - Syringes, 33141320 - Medical needles, 33141624 - Administration sets, 33194120 - Infusion supplies, 33631600 - Antiseptics and disinfectants.
The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.
The TendersOnTime reference is 17545882. The purchaser document reference is 415366-2017.